Wednesday, 8th December 2021
<To guardian.ng
Search

Germany’s CureVac raises $213 million in IPO boosted by pandemic

German coronavirus vaccine developer CureVac says its New York share market debut has netted more than €180 million. Its shares sold at the top end in Friday's placing on the Nasdaq exchange.

Related